1. Home
  2. AX vs BLLN Comparison

AX vs BLLN Comparison

Compare AX & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$97.45

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$126.86

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
BLLN
Founded
1999
2016
Country
United States
United States
Employees
N/A
713
Industry
Savings Institutions
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
AX
BLLN
Price
$97.45
$126.86
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$103.14
$126.71
AVG Volume (30 Days)
406.7K
711.6K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
6.33
N/A
Revenue
$65,789,000.00
N/A
Revenue This Year
$24.76
$46.29
Revenue Next Year
$10.86
$30.14
P/E Ratio
$15.33
N/A
Revenue Growth
1.78
N/A
52 Week Low
$74.89
$61.96
52 Week High
$101.92
$138.70

Technical Indicators

Market Signals
Indicator
AX
BLLN
Relative Strength Index (RSI) 60.75 65.63
Support Level $91.90 $79.07
Resistance Level $100.31 $138.70
Average True Range (ATR) 2.62 6.68
MACD 0.14 0.68
Stochastic Oscillator 73.15 90.04

Price Performance

Historical Comparison
AX
BLLN

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: